Andreessen Horowitz, established in 2009 by Marc Andreessen and Ben Horowitz, is a prominent venture capital firm based in Menlo Park, California. The company specializes in investing in software businesses, with a focus on sectors such as bio + healthcare, artificial intelligence, consumer, enterprise, fintech, and infrastructure. It typically invests in startups at various stages, from seed to late-stage, with a flexible investment range of $0.025 million to $50 million. The firm is known for its focus on disruptive technology and has raised multiple funds to support its investment strategy.
Operating Partner and Head of Crypto Startup Accelerator
Jay Rughani
Investment Partner
Katherine Rundell
Partner, Creators and Consumer GTM
Michael Sandwick
Partner, Consumer
Gil Shafir
Partner
Jeffrey Silverstein
Partner
Steven Sinofsky
Board Partner
Jack Soslow
Partner
Matt Spence
Partner
Nicole Stanners
Fundraise and IR Partner
Angela Strange
General Partner
Jeffrey Stump
Operating Partner
Jamie Sullivan
Partner
Robert H. Swan
Operating Partner
Satish Talluri
Partner
Kimberly Tan
Investment Partner
Carol Tang
Partner
Adela Tomsejova
Partner, Bio + Health
Dalton Turay
Partner
Gabriel Vasquez
Partner
Melissa Wasser
Partner of Fintech Capital Network
Tyler Wilson
Partner
Daisy Wolf
Investing Partner
Carra Wu
Partner, Crypto Investments
Kevin Wu
Partner
Guy Wuollet
Partner
Shangda Xu
Partner
Zeya Yang
Partner
JJ Yu
Partner, Capital Network
Past deals in Health Care
Counsel Health
Seed Round in 2024
Counsel Health helps patients to get access to medical advice virtually.
IDRx
Series B in 2024
IDRx is a clinical-stage biopharmaceutical company focused on developing precision therapies for oncology, specifically targeting gastrointestinal stromal tumors. The company specializes in designing combination therapies that utilize engineered drug combinations to address key tumor escape mechanisms, aiming to enhance treatment efficacy and prolong patient responses. By creating these targeted therapies, IDRx seeks to revolutionize cancer treatment and support healthcare professionals in delivering more effective medicines to patients.
Thyme Care
Series C in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Pomelo Care
Series B in 2024
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.
Milu Health
Seed Round in 2024
Milu Health is a healthcare platform focused on simplifying and reducing the costs of healthcare for employees. The company utilizes electronic health records, claims, and pricing data to uncover opportunities for cost savings in the healthcare system. By providing price transparency, Milu Health helps users identify high-quality and reasonably priced doctors and hospitals for common procedures and surgeries. This approach allows patients to find ways to save on their doctor visits, medical bills, procedures, and prescription drugs, ultimately aiming to make healthcare more accessible and affordable.
Turquoise Health
Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Fortuna Health
Seed Round in 2023
Fortuna Health specializes in simplifying Medicaid access for consumers. Its core business is a user-friendly platform that guides individuals through the complexities of eligibility, enrollment, and renewal processes, ensuring they maintain continuous coverage. The platform also facilitates ongoing recertification, sends renewal reminders, and helps users apply for suitable medical plan programs, ultimately reducing care gaps.
Waymark
Venture Round in 2023
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Thyme Care
Series B in 2023
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Pomelo Care
Series A in 2023
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.
Memora Health
Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Firefly Health
Venture Round in 2022
Firefly Health, Inc. is a Massachusetts-based company that develops an artificial intelligence-driven platform to connect patients with healthcare professionals. Founded in 2016, it focuses on providing primary healthcare services that emphasize accessibility and quality. The platform allows users to navigate their health while offering care for common conditions such as back pain, stomach flu, and women's health issues. Firefly Health utilizes a virtual-first approach, enabling patients to access live video appointments with primary care physicians without membership fees. This model facilitates continuous and intelligent care, empowering patients to make informed health choices and allowing clinicians to deliver consistent and proactive support.
Incredible Health
Series B in 2022
Incredible Health, Inc. operates a technology-driven platform that connects healthcare providers with nursing professionals to address staffing challenges. Founded in 2015 and based in San Francisco, the company offers a subscription-based job portal that facilitates the recruitment process for medical candidates. This platform allows users, including fresh graduates, unemployed medical staff, and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Utilizing AI technology, Incredible Health custom matches healthcare organizations with qualified nurses for hard-to-fill positions, aiming to enhance the hiring experience and improve the lives of healthcare professionals.
IDRx
Series A in 2022
IDRx is a clinical-stage biopharmaceutical company focused on developing precision therapies for oncology, specifically targeting gastrointestinal stromal tumors. The company specializes in designing combination therapies that utilize engineered drug combinations to address key tumor escape mechanisms, aiming to enhance treatment efficacy and prolong patient responses. By creating these targeted therapies, IDRx seeks to revolutionize cancer treatment and support healthcare professionals in delivering more effective medicines to patients.
Tomorrow Health
Series B in 2022
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.
Turquoise Health
Series A in 2022
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Deepcell
Series B in 2022
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.
Memora Health
Venture Round in 2022
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Nitra
Seed Round in 2022
Nitra is a financial technology company focused on enhancing the healthcare industry through efficient and transparent solutions. The company offers a platform that provides machine learning-powered financial software, including credit cards, loans, accounts, payments, and expense management tailored for medical professionals. Nitra's tools help healthcare providers streamline their spending and manage payments in one centralized location, offering a clear overview of daily expenses. The Nitra Visa Business Card rewards users with benefits for every transaction and provides access to discounts through a network of partners. By simplifying accounting and receipt reconciliation, Nitra aims to support healthcare providers in balancing patient care with efficient practice management, delivering modern technology and dedicated support to the sector.
Waymark
Series A in 2022
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Patina Health
Series A in 2021
Patina is a healthcare provider focused on enhancing the aging experience for older adults and their families. The company has developed a care model that prioritizes the unique needs and values of this demographic. By offering personalized and on-demand services, Patina aims to create a healthcare experience that is both human-centered and supportive. This approach allows families to actively participate in the care of their loved ones, ensuring that older adults receive the attention and respect they deserve as they navigate the challenges of aging. Patina's mission is to empower individuals to live their best lives and maintain their dignity as they age.
Thyme Care
Series A in 2021
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Pomelo Care
Seed Round in 2021
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and the first year of their infants' lives. The company's innovative care model combines virtual, round-the-clock clinical support with in-person doula services, effectively addressing medical, behavioral, and social factors that enhance maternal and infant health. By leveraging data science and machine learning, Pomelo Care identifies and manages health risks, leading to improved outcomes and reduced costs. Its online platform delivers personalized care plans and resources that cater to the unique needs of pregnant individuals and newborns, ultimately promoting better health for mothers and their children. Pomelo Care collaborates with employers and various health plans, including commercial and Medicaid providers, to expand access to its high-quality maternity and neonatal care services.
Turquoise Health
Seed Round in 2021
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Nautilus Biotechnology
Post in 2021
Nautilus Biotechnology is a development-stage life sciences company focused on advancing proteomics, the study of proteins and their functions, to enhance therapeutic development and medical diagnostics. The company has created a platform technology that aims to quantify and unravel the complexities of the human proteome. Its flagship product, the Proteomic Analysis System, is a prototype single-molecule instrument designed to facilitate these efforts. The team at Nautilus comprises experts from various disciplines, including protein chemistry, molecular biology, and data science, enabling a multifaceted approach to overcoming challenges in the field. By harnessing this diverse expertise, Nautilus aims to revolutionize drug development and improve healthcare management through personalized and predictive medicine.
Memora Health
Venture Round in 2021
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Tomorrow Health
Series A in 2021
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.
Firefly Health
Series B in 2021
Firefly Health, Inc. is a Massachusetts-based company that develops an artificial intelligence-driven platform to connect patients with healthcare professionals. Founded in 2016, it focuses on providing primary healthcare services that emphasize accessibility and quality. The platform allows users to navigate their health while offering care for common conditions such as back pain, stomach flu, and women's health issues. Firefly Health utilizes a virtual-first approach, enabling patients to access live video appointments with primary care physicians without membership fees. This model facilitates continuous and intelligent care, empowering patients to make informed health choices and allowing clinicians to deliver consistent and proactive support.
Deepcell
Series A in 2020
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.
BioAge Labs
Series C in 2020
BioAge Labs, Inc. is a biotechnology company focused on developing therapies to address aging and age-related diseases. The company utilizes a systems biology and artificial intelligence platform to identify key drug targets that influence aging and analyze extensive datasets to uncover the molecular drivers of age-related conditions. BioAge Labs is advancing several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor designed to activate genes involved in critical biological processes such as tissue regeneration and vascular remodeling. Additionally, BGE-175, an orally administered inhibitor of the prostaglandin D2 DP1 signaling pathway, aims to mitigate risks associated with immune aging and respiratory infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to discovering and developing innovative treatments that harness the biology of human aging.
Honor
Series D in 2020
Honor is a leading senior care network and technology platform that focuses on enhancing the quality of life for older adults and their families. Founded in 2014 by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg in San Francisco, California, Honor has established itself as a pioneer in the home care industry. The company offers expert in-home care services for seniors, leveraging an integrated system of third-party care providers. By combining scalable workforce management with personalized care, Honor enables older adults to live safely and comfortably in their own homes. In 2021, Honor expanded its reach by acquiring Home Instead, enhancing its capabilities through a global network and a relationship-based care model. This strategic move positions Honor to address the evolving needs of aging adults and professional caregivers worldwide.
PatientPing
Series C in 2020
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.
Nautilus Biotechnology
Series B in 2020
Nautilus Biotechnology is a development-stage life sciences company focused on advancing proteomics, the study of proteins and their functions, to enhance therapeutic development and medical diagnostics. The company has created a platform technology that aims to quantify and unravel the complexities of the human proteome. Its flagship product, the Proteomic Analysis System, is a prototype single-molecule instrument designed to facilitate these efforts. The team at Nautilus comprises experts from various disciplines, including protein chemistry, molecular biology, and data science, enabling a multifaceted approach to overcoming challenges in the field. By harnessing this diverse expertise, Nautilus aims to revolutionize drug development and improve healthcare management through personalized and predictive medicine.
Tomorrow Health
Seed Round in 2020
Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.
Devoted
Series C in 2020
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.
Incredible Health
Series A in 2019
Incredible Health, Inc. operates a technology-driven platform that connects healthcare providers with nursing professionals to address staffing challenges. Founded in 2015 and based in San Francisco, the company offers a subscription-based job portal that facilitates the recruitment process for medical candidates. This platform allows users, including fresh graduates, unemployed medical staff, and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Utilizing AI technology, Incredible Health custom matches healthcare organizations with qualified nurses for hard-to-fill positions, aiming to enhance the hiring experience and improve the lives of healthcare professionals.
BioAge Labs
Series B in 2019
BioAge Labs, Inc. is a biotechnology company focused on developing therapies to address aging and age-related diseases. The company utilizes a systems biology and artificial intelligence platform to identify key drug targets that influence aging and analyze extensive datasets to uncover the molecular drivers of age-related conditions. BioAge Labs is advancing several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor designed to activate genes involved in critical biological processes such as tissue regeneration and vascular remodeling. Additionally, BGE-175, an orally administered inhibitor of the prostaglandin D2 DP1 signaling pathway, aims to mitigate risks associated with immune aging and respiratory infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to discovering and developing innovative treatments that harness the biology of human aging.
Honor
Series C in 2018
Honor is a leading senior care network and technology platform that focuses on enhancing the quality of life for older adults and their families. Founded in 2014 by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg in San Francisco, California, Honor has established itself as a pioneer in the home care industry. The company offers expert in-home care services for seniors, leveraging an integrated system of third-party care providers. By combining scalable workforce management with personalized care, Honor enables older adults to live safely and comfortably in their own homes. In 2021, Honor expanded its reach by acquiring Home Instead, enhancing its capabilities through a global network and a relationship-based care model. This strategic move positions Honor to address the evolving needs of aging adults and professional caregivers worldwide.
Deepcell
Seed Round in 2017
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.
BioAge Labs
Series A in 2017
BioAge Labs, Inc. is a biotechnology company focused on developing therapies to address aging and age-related diseases. The company utilizes a systems biology and artificial intelligence platform to identify key drug targets that influence aging and analyze extensive datasets to uncover the molecular drivers of age-related conditions. BioAge Labs is advancing several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor designed to activate genes involved in critical biological processes such as tissue regeneration and vascular remodeling. Additionally, BGE-175, an orally administered inhibitor of the prostaglandin D2 DP1 signaling pathway, aims to mitigate risks associated with immune aging and respiratory infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to discovering and developing innovative treatments that harness the biology of human aging.
PatientPing
Series B in 2016
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.
Cardiogram
Seed Round in 2016
Cardiogram, Inc., established in 2015 and based in San Francisco, California, specializes in developing wearable devices and applications to monitor and analyze heart health. The company's technology enables users to track heart rate measurements, providing insights into how their heart responds during workouts and how various factors such as stress, diet, and exercise affect their resting heart rate. The application supports cardio-tracking for devices like the Apple Watch and Android Wear, allowing users to detect heartbeats, monitor sleep, and maintain fitness. By enabling users to visualize and share their heart rate data, Cardiogram aims to help prevent serious heart-related issues such as strokes.
uBiome
Series A in 2014
uBiome, Inc. was a microbial genomics company based in San Francisco, California, founded in 2012. It specialized in sequencing-based clinical microbiome tests, offering products such as SmartGut, a test for identifying pathogenic and commensal microorganisms related to infections, and SmartJane, a women's health screening test that detects various conditions including HPV and STIs. The company also provided Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. By leveraging precision sequencing combined with machine learning and artificial intelligence, uBiome aimed to enhance the understanding of the human microbiome, enabling healthcare providers to deliver more accurate diagnoses and empowering patients to manage their health more effectively. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019.
Massive Health
Seed Round in 2011
Massive Health is a company dedicated to promoting healthy living through innovative technology and design. Founded in 2010 and led by Aza Raskin, a former creative lead at Firefox, the company aims to make health-related information accessible and engaging for everyone. Its flagship product, The Eatery, is an iPhone application that encourages users to improve their dietary habits by allowing them to take photos of their meals. This approach not only makes tracking food consumption enjoyable but also provides valuable feedback on the healthiness of their choices, assisting users in developing healthier habits. Massive Health's focus extends to helping individuals manage chronic conditions like diabetes through diet and exercise, emphasizing a holistic approach to wellness.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.